FDA Approves First Generic Versions of FARXIGA - Quiz - MDSpire

FDA Approves First Generic Versions of FARXIGA

Agency approves multiple dapagliflozin generics to reduce heart failure hospitalization risk and improve glycemic control in adults with type 2 diabetes

  • By

  • Kathryn Wighton

  • April 7, 2026

  • 2 min

Share

Original Source(s)

FDA Approves First Generic Versions of FARXIGA

  • by Kathryn Wighton

  • April 7, 2026

Related Content

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes

Sex differences in iron stores and associations of body iron with cardiovascular risk factors in the middle-aged general population

The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease